Inventor · disambiguated record
Judith A. Fox
Also filed as: FOX JUDITH A
7 granted patents·14 pending applications·33 citations·filing 2000–2020
81Inventor score
Files withAMPHIVENA THERAPEUTICS INC4FOX JUDITH A4GENENTECH INC4SUNESIS PHARMACEUTICALS INC2BRETTMAN LEE R1
Top patents by PatentIndex Score
21 records- 0192US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0290US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0388US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0479US8088609B2CAB moleculesFOX JUDITH A·Filed 2005·Granted Jan 3, 2012·2 cites·7 claims
- 0568US2009169569A1APO-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2008·Application pending·0 cites
- 0665US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0763US8101728B2TAB moleculesFOX JUDITH A·Filed 2006·Granted Jan 24, 2012·0 cites·6 claims
- 0860US2020002423A1Method of administering an antibodyMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 0959US8188240B2Tab moleculesFOX JUDITH A·Filed 2011·Granted May 29, 2012·0 cites·6 claims
- 1058US2014186345A1Method of administering an antibodyGENENTECH INC·Filed 2014·Application pending·0 cites
- 1155US2011160440A1Cab MoleculesGENENCOR INT·Filed 2004·Application pending·0 cites
- 1253US2005095238A1Method of administering an antibodyGENENTECH INC·Filed 2003·Application pending·0 cites
- 1351US2012034243A1Method of Administering an AntibodyBRETTMAN LEE R·Filed 2011·Application pending·0 cites
- 1450US2004005314A1Apo-2l receptor agonist and cpt-11 synergismESCANDON ENRIQUE·Filed 2001·Application pending·0 cites
- 1548US2015202189A1Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activitySUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1648US2011059104A1Apo-2L receptor agonist and CPT-11 synergismGENENTECH INC·Filed 2010·Application pending·0 cites
- 1747US8728470B2CAB moleculesFOX JUDITH A·Filed 2011·Granted May 20, 2014·0 cites·20 claims
- 1845US2001046496A1Method of administering an antibodyFiled 2000·Application pending·0 cites
- 1943US2006141456A1Methods and compositions for milieu-dependent binding of a targeted agent to a targetEDWARDS CYNTHIA·Filed 2003·Application pending·0 cites
- 2040US2017182015A1Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activitySUNESIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2134US2012148564A1Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activityHAWTIN RACHAEL E·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Judith A. Fox files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →